Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jeffrey R. Curtis, Vibeke Strand, Steven Golombek, Lixia Zhang, Angus Wong, Mark C. Zielinski, Viatcheslav R. Akmaev, Alif Saleh, Sam Asgarian & Johanna B. Withers. (2022) Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis. Expert Review of Molecular Diagnostics 22:10, pages 973-982.
Read now
Read now
Sang Hee Park, Xue Han, Francis Lobo, David Kratochvil & Dipen Patel. (2020) A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis. Journal of Medical Economics 23:6, pages 624-630.
Read now
Read now
Ana Márquez, Javier Martín & F. David Carmona. (2016) Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis. Expert Review of Molecular Diagnostics 16:6, pages 663-675.
Read now
Read now
David S Gibson, Michael J Bustard, Cathy M McGeough, Helena A Murray, Martin A Crockard, Andrew McDowell, Jayne K Blayney, Philip V Gardiner & Anthony J Bjourson. (2015) Current and future trends in biomarker discovery and development of companion diagnostics for arthritis. Expert Review of Molecular Diagnostics 15:2, pages 219-234.
Read now
Read now
Articles from other publishers (30)
Kartik Bhamidipati & Kevin Wei. (2022) Precision medicine in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 36:1, pages 101742.
Crossref
Crossref
Zahraa I. Selim, Rania M. Gamal, Lobna A Araby, Eman R. Badawy & Nada M. Gamal. (2022) Collagen triple helix repeat containing 1 (CTHRC1) protein: A promising biomarker for evaluation of rheumatoid arthritis patients. The Egyptian Rheumatologist 44:1, pages 11-14.
Crossref
Crossref
Georgia-Eirini Deligiannidou, Vasiliki Gougoula, Eugenia Bezirtzoglou, Christos Kontogiorgis & Theodoros K. Constantinides. (2021) The Role of Natural Products in Rheumatoid Arthritis: Current Knowledge of Basic In Vitro and In Vivo Research. Antioxidants 10:4, pages 599.
Crossref
Crossref
Manuela Cassotta, Tamara Y. Forbes-Hernandez, Danila Cianciosi, Maria Elexpuru Zabaleta, Sandra Sumalla Cano, Irma Dominguez, Beatriz Bullon, Lucia Regolo, Josè Miguel Alvarez-Suarez, Francesca Giampieri & Maurizio Battino. (2021) Nutrition and Rheumatoid Arthritis in the ‘Omics’ Era. Nutrients 13:3, pages 763.
Crossref
Crossref
Gianluigi Pasta, Salvatore Annunziata, Alberto Polizzi, Laura Caliogna, Eugenio Jannelli, Alessandro Minen, Mario Mosconi, Francesco Benazzo & Matteo Nicola Dario Di Minno. (2020) The Progression of Hemophilic Arthropathy: The Role of Biomarkers. International Journal of Molecular Sciences 21:19, pages 7292.
Crossref
Crossref
Byung Kil Kim, Jennifer R. Fonda, Richard L. Hauger, Graziano Pinna, George M. Anderson, Ivan T. Valovski & Ann M. Rasmusson. (2020) Composite contributions of cerebrospinal fluid GABAergic neurosteroids, neuropeptide Y and interleukin-6 to PTSD symptom severity in men with PTSD. Neurobiology of Stress 12, pages 100220.
Crossref
Crossref
E. Carlos Rodriguez-Merchan. (2020) Serological biomarkers in hemophilic arthropathy: Can they be used to monitor bleeding and ongoing progression of blood-induced joint disease in patients with hemophilia?. Blood Reviews 41, pages 100642.
Crossref
Crossref
Katie Tuckwell, Cem Gabay, Thierry Sornasse, Ruediger Paul Laubender, Jianmei Wang & Michael J. Townsend. (2019) Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab. Advances in Rheumatology 59:1.
Crossref
Crossref
J. P. M. Blair, C. Bager, A. Platt, M. Karsdal & A. -C. Bay-Jensen. (2019) Identification of pathological RA endotypes using blood-based biomarkers reflecting tissue metabolism. A retrospective and explorative analysis of two phase III RA studies. PLOS ONE 14:7, pages e0219980.
Crossref
Crossref
Askhat Myngbay, Yergali Bexeitov, Altynai Adilbayeva, Zhenisbek Assylbekov, Bogdan P. Yevstratenko, Rysgul M. Aitzhanova, Bakhyt Matkarimov, Vyacheslav A. Adarichev & Jeannette Kunz. (2019) CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis. Frontiers in Immunology 10.
Crossref
Crossref
Xu Li, Lang Ding, Xue Li, He Zhu, Ebtesam A. Gashash, Zhanguo Li, Peng George Wang & Cheng Ma. (2019) An integrated proteomic and glycoproteomic study for differences on glycosylation occupancy in rheumatoid arthritis. Analytical and Bioanalytical Chemistry 411:7, pages 1331-1338.
Crossref
Crossref
Gary M Oderda, Grant D Lawless, Grace C Wright, Samuel R Nussbaum, Renwyck Elder, Kibum Kim & Diana I Brixner. (2018) The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs. Personalized Medicine 15:4, pages 291-301.
Crossref
Crossref
Tsutomu Takeuchi. (2018) Biomarkers as a treatment guide in rheumatoid arthritis. Clinical Immunology 186, pages 59-62.
Crossref
Crossref
S. Chandrashekara, Masoodi Mukhtar Ahmad, Panchagnula Renuka, K. R. Anupama & K. Renuka. (2017) Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis. International Journal of Rheumatic Diseases 20:10, pages 1457-1467.
Crossref
Crossref
Carl Orr, Elsa Vieira-Sousa, David L. Boyle, Maya H. Buch, Christopher D. Buckley, Juan D. Cañete, Anca I. Catrina, Ernest H. S. Choy, Paul Emery, Ursula Fearon, Andrew Filer, Danielle Gerlag, Frances Humby, John D. Isaacs, Søren A. Just, Bernard R. Lauwerys, Benoit Le Goff, Antonio Manzo, Trudy McGarry, Iain B. McInnes, Aurélie Najm, Constantino Pitzalis, Arthur Pratt, Malcolm Smith, Paul P. Tak, Sander W. Tas, Rogier Thurlings, João E. Fonseca & Douglas J. Veale. (2017) Synovial tissue research: a state-of-the-art review. Nature Reviews Rheumatology 13:8, pages 463-475.
Crossref
Crossref
David L. Boyle & William H. Robinson. 2017. Kelley and Firestein's Textbook of Rheumatology. Kelley and Firestein's Textbook of Rheumatology
509
519
.
Gregory J. Dennis, Gonzalo Fernandez, Heather Iocca & Holly Hilton. 2017. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases
15
33
.
J. Oldenburg, R. Zimmermann, O. Katsarou, E. Zanon, E. Kellermann, B. Lundin & P. Ellinghaus. (2016) Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores. Haemophilia 22:5, pages 760-764.
Crossref
Crossref
Elisabetta Marulli, Alessandra Aloisi, Paolo Di Giuseppe & Rosaria Rinaldi. (2016) Micro and nanotechnology for early diagnosis and detection of rheumatic diseases-molecular markers. BioChip Journal 10:3, pages 189-197.
Crossref
Crossref
Benedikte Serruys, Thomas Stöhr, Hans Ulrichts, Katrien Vanheusden & Maarten Van Roy. 2016. Translational Medicine. Translational Medicine
1
33
.
Nitya Nair, Henrik E Mei, Shih-Yu Chen, Matthew Hale, Garry P Nolan, Holden T Maecker, Mark Genovese, C Garrison Fathman & Chan C Whiting. (2015) Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy. Arthritis Research & Therapy 17:1.
Crossref
Crossref
Junji Hayashi, Makoto Kihara, Harubumi Kato & Toshihide Nishimura. (2015) A proteomic profile of synoviocyte lesions microdissected from formalin-fixed paraffin-embedded synovial tissues of rheumatoid arthritis. Clinical Proteomics 12:1.
Crossref
Crossref
Kazuko Uno, Kazuyuki Yoshizaki, Mitsuhiro Iwahashi, Jiro Yamana, Seizo Yamana, Miki Tanigawa & Katsumi Yagi. (2015) Pretreatment Prediction of Individual Rheumatoid Arthritis Patients’ Response to Anti-Cytokine Therapy Using Serum Cytokine/Chemokine/Soluble Receptor Biomarkers. PLOS ONE 10:7, pages e0132055.
Crossref
Crossref
Mark J. Soloski, Lauren A. Crowder, Lauren J. Lahey, Catriona A. Wagner, William H. Robinson & John N. Aucott. (2014) Serum Inflammatory Mediators as Markers of Human Lyme Disease Activity. PLoS ONE 9:4, pages e93243.
Crossref
Crossref
Glynn DennisJrJr, Cécile TJ Holweg, Sarah K Kummerfeld, David F Choy, A Francesca Setiadi, Jason A Hackney, Peter M Haverty, Houston Gilbert, Wei Yu Lin, Lauri Diehl, S Fischer, An Song, David Musselman, Micki Klearman, Cem Gabay, Arthur Kavanaugh, Judith Endres, David A Fox, Flavius Martin & Michael J Townsend. (2014) Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Research & Therapy 16:2.
Crossref
Crossref
Mehmet Tevfik Dorak & Yusuf Yazici. 2014. Understanding Evidence-Based Rheumatology. Understanding Evidence-Based Rheumatology
79
126
.
Menha Swellam, Khadiga M. Abu Gabal & Samar Samir Youssef. (2013) Interleukin-1 receptor antagonist gene polymorphism and hepcidin in rheumatoid arthritis: Correlations with clinical and laboratory indices of disease activity. IUBMB Life, pages n/a-n/a.
Crossref
Crossref
Rocky Strollo, Frederique Ponchel, Vivianne Malmström, Paola Rizzo, Michele Bombardieri, Claire Y. Wenham, Rebecca Landy, David Perret, Fiona Watt, Valerie M. Corrigall, Paul G. Winyard, Paolo Pozzilli, Philip G. Conaghan, Gabriel S. Panayi, Lars Klareskog, Paul Emery & Ahuva Nissim. (2013) Autoantibodies to Posttranslationally Modified Type II Collagen as Potential Biomarkers for Rheumatoid Arthritis. Arthritis & Rheumatism 65:7, pages 1702-1712.
Crossref
Crossref
Magdalena Przybysz, Krzysztof Borysewicz & Iwona Kątnik-Prastowska. (2012) Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients. Rheumatology International 33:1, pages 37-43.
Crossref
Crossref
John D. MacKenzie, Yi-Fen Yen, Dirk Mayer, James S. Tropp, Ralph E. Hurd & Daniel M. Spielman. (2011)
Detection of Inflammatory Arthritis by Using Hyperpolarized
13
C-Pyruvate with MR Imaging and Spectroscopy
. Radiology 259:2, pages 414-420.
Crossref
Crossref